Marimed (MRMD) Interest & Investment Income (2018 - 2026)

Marimed (MRMD) has reported Interest & Investment Income for 9 consecutive years, with $36000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Interest & Investment Income rose 44.0% year-over-year to $36000.0 in Q2 2026; TTM through Jun 2026 was $200000.0, a 78.57% increase from a year earlier, with the FY2025 full-year figure at $177000.0, up 55.26% from the prior year.
• Interest & Investment Income was $36000.0 for Q2 2026 at Marimed, roughly flat from $36000.0 in the prior quarter.
• Over five years, Interest & Investment Income peaked at $318000.0 in Q2 2022 and troughed at $24000.0 in Q1 2025.
• A 5-year average of $88444.4 and a median of $36000.0 in 2026 frame the typical range for Interest & Investment Income.
• Across the five-year window, Interest & Investment Income soared 1738.46% in 2022 and sank 88.7% in 2023, its largest moves.
• Over 5 years, Interest & Investment Income stood at $239000.0 in 2022, then slumped by 88.7% to $27000.0 in 2023, then surged by 40.74% to $38000.0 in 2024, then soared by 171.05% to $103000.0 in 2025, then slumped by 65.05% to $36000.0 in 2026.
• The last three Interest & Investment Income figures came in at $36000.0 (Q2 2026), $36000.0 (Q1 2026), and $103000.0 (Q4 2025), per Business Quant data.